Extracellular matrix production stimulation

"Extracellular matrix production stimulation" refers to increasing the synthesis and deposition of extracellular matrix components (e.g., collagens, proteoglycans, glycoproteins) by cells, a systems-level process governed by many pathways and receptors (e.g., integrins, growth factor receptors), enzymes (e.g., lysyl oxidases, matrix metalloproteinases), and ECM-associated regulators. The ECM provides structural support and serves as a reservoir and regulator of growth factors and cytokines, thereby controlling fundamental cell behaviors such as adhesion, migration, polarity, proliferation, differentiation, and apoptosis. ECM composition and mechanics guide development and tissue morphogenesis, while aberrant remodeling and stiffness contribute to diseases including fibrosis and cancer. Because this is a process and not a single molecular entity, it should not be treated as a canonical drug target; instead, specific upstream mediators (e.g., TGF‑β signaling components, integrins, LOX family, DDRs) or ECM proteins would be the appropriate molecular targets in drug development contexts.

Other names

Extracellular matrix (ECM) upregulationECM synthesis stimulationMatrix production enhancementECM deposition increase